Prof Paresh Vyas and his team are investigating haematopoietic stem cells (HSCs) and clonal haematopoiesis (CH), associated with cardiovascular disease and blood cancers. They have been collecting bone marrow samples from otherwise well patients having hip-replacement operations to further understand the mechanisms involved to help develop targeted therapies.
More recently the team have also been studying patients with COVID-19, to understand if CH has an impact on the clinical course of COVID-19. Find out more about this research on the Cancer Research UK Oxford Centre's website.